Sunday, December 28, 2008
The annual San Antonio Breast Cancer Symposium (SABCS), held earlier this month, is the premier scientific symposium in the world for breast oncologists, breast cancer researchers, and associated healthcare professionals. Its mission is to “encompass the full spectrum of breast cancer research ...
P.J. wasn't there also a Herceptin study that was done on survival rates with node negative patients.. that herceptin is very benificial.. the whole infalmmatory process...??? did you have any insight into that???? I read a blurp in the paper. Can you clear up any of it?
Hi - There are several ongoing studies that seem to show Herceptin added to chemo is beneficial in preventing recurrence for node-negative (HER2-positive) BC survivors—is that what you meant? Maybe the FinHER trial is what you're thinking of? See if you can find the piece you read, I'll look into it- PJH